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Evaluation of late-onset sepsis antibiotic utilization within two tertiary healthcare center neonatal 
intensive care units and revision of empiric late-onset sepsis antibiotic prescribing guidelines
Alex Creevan, PharmD, Sara Clark, PharmD, Anavice Jimenez, PharmD Candidate, Michael Garcia, PharmD
Background Conclusions
References
• Neonatal late-onset sepsis (LOS) is commonly 
defined as an infection occurring after the first 72 
hours of life1. LOS is a common complication of 
prolonged admission to the neonatal intensive care 
unit (NICU) and is a major cause of morbidity and 
mortality.2
• Due to the risks associated with LOS, antibiotics 
are often started inappropriately in this population 
which can lead to multi-drug resistant bacteria, 
increased healthcare costs, alterations in the 
microbiome and an increased risk of necrotizing 
enterocolitis (NEC) and mortality.3-5
• Current Providence Oregon Regional empiric 
antibiotic guidelines for suspected LOS in the NICU 
do not provide clear prescribing recommendations, 
do not offer dosing recommendations, are likely 
underutilized by providers, and have not been 
updated since 2011. All of which could lead to 
inappropriate antibiotic prescribing.
• In October 2019, providers at two tertiary medical 
centers agreed upon using American Academy of 
Pediatrics (AAP) Red Book6 for antibiotic dosing in 
neonates.
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• To retrospectively evaluate the appropriateness of 
antibiotic utilization in the NICU at two tertiary 
medical centers
• To promote standardization of antibiotic 
prescribing for LOS through revision of the 2011 
regional empiric antibiotic guidelines for suspected 
LOS in the NICU
Study design: Retrospective chart review
Setting: Neonatal intensive care units at two tertiary 
healthcare facilities
Inclusion criteria: 
• Admitted to the NICU at two tertiary medical 
centers
• Received at least one course of antibiotics starting 
after 72 hours of life
Exclusion criteria:
• Patients were excluded if inclusion criteria were 
not met
Objectives
Primary Objective: 
• Measure and evaluate appropriateness of 
antibiotic utilization in the NICU at two tertiary 
medical centers and compare to the 2011 
Providence Oregon regional guidelines and 
recommendations from neonatal antibiotic dosing 
references (AAP Red Book, Lexicomp7, Neofax8, or 
other)
Secondary Objective: 
• Revision and implementation of new LOS 
guidelines (in process)
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Results • There were 35 patients identified as having at least 
one occurrence of LOS, with 45 occurrences 
identified in total. After excluding antibiotics dosed 
by pharmacy (vancomycin and gentamicin), 55 
antibiotics were evaluated based on neonatal 
antibiotic dosing reference. 
• Nearly half (47%) of the empiric antibiotic regimes 
were not consistent with 2011 Regional guidelines. 
This variation is likely attributable to the vagueness 
of the guideline.
• Ampicillin and gentamicin were chosen as empiric 
antibiotics in 11% of empiric regimens. 
• Regional guidelines only recommend ampicillin 
and gentamicin for early-onset sepsis.
• This was one factor that attributed to the high 
percentage of antibiotics categorized as “does 
not match guideline.”
• While majority (53%) of dosing and/or dosing 
frequency of empiric antibiotics matched AAP Red 
Book, antibiotic dosing reference utilization was 
highly variable. 
• For regimens in which Red Book was not utilized, 
the most frequently used dosing reference was 
Neofax at 29%, followed by “other” at 13%. Dosing 
was categorized as “other” if it did not match one 
of the specified dosing references. Lexicomp was 
used 5% of the time. It should be noted that 
Lexicomp frequently cites Red Book, and was only 
counted if the recommendation was not consistent 
with Red Book dosing.  
• Prescribers would likely benefit from a standardized 
guideline for prescribing empiric antibiotics that 
includes dosing based on AAP Red Book 
recommendations. 
Study Limitations:
• Retrospective, non-randomized study
• Small sample size
• Revision and implementation of new late-onset 
sepsis guidelines based on Red Book dosing 
recommendations
Characteristics n (%)
Sex n=35
Male 24 (69)
Site n=35
NICU A 30 (86)
NICU B 5 (14)
Birthweight classification n=35
ELBW (< 1000 g) 20 (57)
VLBW (< 1500 g) 7 (20)
LBW (< 2500 g) 7 (20)
Preterm birth category n=35
EPT (< 28 weeks) 24 (69)
VPT (28-32 weeks) 5 (14)
MLPT (32-37 weeks) 5 (14)
Term (> 37 weeks) 1 (3)
Diagnosis n=45
Presumed sepsis 15 (33)
Bacteremia 14 (31)
Presumed pneumonia 6 (13)
Bacterial pneumonia 5 (11)
Necrotizing enterocolitis 3 (7)
Viral meningitis 1 (2)
Viral pneumonia 1 (2)
ELBW = Extremely low birth weigh; VLBW = Very low birth weight; LBW = 
Low birth weight; EPT = Extremely preterm; VPT = Very preterm; MTLP = 
Moderate to late preterm
Most Frequent Empiric Regimens n (%) n=45
Gentamicin/nafcillin 11 (24)
Ceftazidime/vancomycin 6 (13)
Ampicillin/gentamicin 5 (11)
Ceftazidime/nafcillin 4 (9)
Cefepime/vancomycin 3 (7)
Risk Factors n (%) n=45
Central line 22 (49)
Total parenteral nutrition 23 (51)
n=35
Previous IV antibiotics 25 (71)
Chronic lung disease 18 (51)
Patent ductus arteriosus 13 (37)
Maternal GBS status n=35
Positive 8 (23)
Negative 12 (34)
Unknown 15 (43)
Respiratory support n=35
Mechanical ventilation 17 (49)
Other 15 (43)
None 3 (9)
GBS =Group B Streptococcus
Organism
Blood
GBS 4
E.coli 3
MSSA 2
Klebsiella pneumoniae 1
E. coli 1
Serratia marcescens 1
Enterococcus faecalis 1
Staph. hominis 1
CoNS 1
Klebsiella oxytoca 1
Respiratory
Klebsiella oxytoca 3
MSSA 2
Serratia marcescens 1
E. coli 1
Klebsiella pneumoniae 1
Total 24
GBS = Group B Streptococcus; MSSA = methicillin susceptible Staph. 
aureus; CoNS = coagulase-negative Staph.
Figure 1. Antibiotic prescribing compared to 2011 
Providence Oregon Regional Guidelines
Figure 2. Neonatal antibiotic dosing reference utilization 
frequency after excluding antibiotics dosed by pharmacy
Figure 3. Patient outcomes at the end of NICU stay
Table 1. Patient demographics
Table 2. Most frequently ordered empiric antibiotic 
regimens 
Table 3. Late-onset sepsis risk factors Table 4. Number of cultures stratified by 
organism and source
RB = Red Book; Neo = Neofax; Lexi = Lexicomp
